"ADP-ribosyl Cyclase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A membrane-bound or cytosolic enzyme that catalyzes the synthesis of CYCLIC ADP-RIBOSE (cADPR) from nicotinamide adenine dinucleotide (NAD). This enzyme generally catalyzes the hydrolysis of cADPR to ADP-RIBOSE, as well, and sometimes the synthesis of cyclic ADP-ribose 2' phosphate (2'-P-cADPR) from NADP.
Descriptor ID |
D036541
|
MeSH Number(s) |
D08.811.277.450.430.400.060 D08.811.913.400.725.115.660.060
|
Concept/Terms |
ADP-ribosyl Cyclase- ADP-ribosyl Cyclase
- ADP ribosyl Cyclase
- Cyclase, ADP-ribosyl
- ADPR Cyclase
- Cyclase, ADPR
- Adenosine Diphosphate Ribose Cyclase
- ADP Ribose Cyclase
- Cyclase, ADP Ribose
- Ribose Cyclase, ADP
Cyclic ADP-ribose Hydrolase- Cyclic ADP-ribose Hydrolase
- ADP-ribose Hydrolase, Cyclic
- Cyclic ADP ribose Hydrolase
- Hydrolase, Cyclic ADP-ribose
- cADPR Hydrolase
- Hydrolase, cADPR
2'-P-ADPR Cyclase- 2'-P-ADPR Cyclase
- 2' P ADPR Cyclase
- Cyclase, 2'-P-ADPR
- 2'-Phospho-adenosine Diphosphate Ribose Cyclase
- 2' Phospho adenosine Diphosphate Ribose Cyclase
|
Below are MeSH descriptors whose meaning is more general than "ADP-ribosyl Cyclase".
Below are MeSH descriptors whose meaning is more specific than "ADP-ribosyl Cyclase".
This graph shows the total number of publications written about "ADP-ribosyl Cyclase" by people in this website by year, and whether "ADP-ribosyl Cyclase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 0 | 2 | 2 |
2013 | 0 | 1 | 1 |
2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "ADP-ribosyl Cyclase" by people in Profiles.
-
Genome-Wide Meta-Analysis of Blood Pressure Response to ?1-Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies). J Am Heart Assoc. 2019 08 20; 8(16):e013115.
-
Regulation of renin release via cyclic ADP-ribose-mediated signaling: evidence from mice lacking CD38 gene. Cell Physiol Biochem. 2013; 31(1):44-55.
-
The activation profile of tumour-associated reactive T-cells differs in the nodular and diffuse patterns of lymphocyte predominant Hodgkin's disease. Histopathology. 2004 Jun; 44(6):561-9.
-
Virological and immunological outcomes in HIV-1-infected Chinese patients treated with a combination of Efavirenz and Indinavir for 48 weeks. Chin Med J (Engl). 2004 Mar; 117(3):347-52.
-
Profiling of the cell surface proteome. Proteomics. 2003 Oct; 3(10):1947-54.
-
Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia. Cancer. 2003 Apr 15; 97(8):1914-9.
-
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood. 2003 Jun 15; 101(12):4944-51.
-
Fine-needle aspiration cytology of a case of HIV-associated anaplastic myeloma. Diagn Cytopathol. 2002 Oct; 27(4):218-22.
-
Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia. Cancer. 2002 Sep 01; 95(5):1071-5.
-
The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia. Blood. 2002 Aug 15; 100(4):1215-9.